Article
Statistical Considerations for Clinical Trials During COVID-19: Phase 1 Cancer Trials
LinkedIn
Document Type
Article
Publication Date
4-20-2020
Disciplines
Abstract
Oncology drug discovery and proper conduct of cancer clinical trials are essential to our battle against cancer. According to a 2015 Center for Disease Control and Prevention (CDC) report, the expected cancer cases and deaths in 2020 are 1.9 million and 630,000. While the world is fighting COV-19 pandemic, it is also important to be more creative than ever to continue anti-cancer drug development in a safe manner - without exposing cancer patients to unnecessary COVID-19 risks while maintaining the integrity of cancer clinical trials.
Citation Information
Michael T. Tirgan, Qing Liu and Karl E. Peace. "Statistical Considerations for Clinical Trials During COVID-19: Phase 1 Cancer Trials" LinkedIn (2020) Available at: http://works.bepress.com/karl_peace/381/